| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | -0.018 | 0.8 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.0088 | 0.8 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.8 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.8 |
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | -0.0066 | 0.9 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | -0.0099 | 0.9 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.0062 | 0.9 |
| mRNA | isonicotinohydroxamic acid | CTRPv2 | pan-cancer | AAC | -0.0079 | 0.9 |